Skip to main content

Want a detailed portfolio tracker?

Kala Bio (KALA) P/E (2017 - 2026)

Kala Bio (KALA) P/E from Oct 2, 2017 to Jul 21, 2026. The TTM Kala Bio (KALA) P/E is -0.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kala Bio (KALA)

YearP/EChange
2026-0.18-96.57%
2025-5.13-85.86%
2024-36.29+118.91%
2023-16.58-13.13%
2022-19.08-30.65%
2021-27.52-85.01%
2020-183.62+171.89%
2019-67.53-32.81%
2018-100.52-95.45%
2017-2.21KN/A

Comparison Kala Bio (KALA) P/E with competitors

Kala Bio (KALA) P/E is -0.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.96%
NBYStablecoin Development Corp0.00-102.44%
ENLVEnlivex Ltd0.07-142.44%
FGENFibroGen Inc0.24-236.17%
CHRSCoherus Biosciences Inc0.85-581.37%
FBIOFortress Biotech Inc0.95-638.38%
ORMPOramed Pharmaceuticals Inc1.50-952.68%
AGENAgenus Inc3.01-1807.34%
INVAInnoviva Inc3.15-1889.26%
VXRTVaxart Inc3.55-2113.75%
CRMDCorMedix Inc3.63-2158.40%
CVACCureVac N.V.4.45-2622.01%
GLPGGalapagos NV4.86-2856.42%
SRPTSarepta Therapeutics Inc4.88-2869.59%
ABEOAbeona Therapeutics Inc5.39-3156.31%
ABUSArbutus Biopharma Corp5.60-3274.37%
ZVRAZevra Therapeutics Inc5.89-3439.80%
SPROSpero Therapeutics Inc6.23-3633.37%
CGENCompugen Ltd6.31-3681.87%
RIGLRigel Pharmaceuticals6.87-3998.49%
SLXNSilexion Therapeutics Corp7.30-4239.03%
OMEROmeros Corporation9.26-5352.45%
AUPHAurinia Pharmaceuticals Inc9.58-5537.51%
PLXProtalix BioTherapeutics Inc10.89-6278.43%
ACADAcadia Pharmaceuticals Inc11.73-6753.55%
TBPHTheravance Biopharma Inc12.26-7056.27%
ADMAAdma Biologics Inc12.42-7144.78%
HRMYHarmony Biosciences Holdings Inc13.82-7940.15%
SABSSAB Biotherapeutics Inc14.14-8119.43%
NAGENiagen Bioscience Inc14.82-8506.28%
INCYIncyte Corp15.82-9076.09%
REGNRegeneron Pharmaceuticals Inc15.86-9095.44%
PBYIPuma Biotechnology Inc17.32-9923.15%
CPRXCatalyst Pharmaceuticals Inc17.44-9993.28%
EXELExelixis Inc17.54-10049.27%
TGTXTG Therapeutics Inc18.97-10859.40%
MDXGMimedx Group Inc20.55-11759.39%
XOMAXOMA Royalty Corp22.87-13077.10%
ARGXArgen X SE24.30-13884.56%
CTMXCytomX Therapeutics Inc24.82-14181.32%
XOMAOXOMA Royalty Corp25.34-14478.43%
HALOHalozyme Therapeutics Inc25.62-14636.65%
XOMAPXOMA Royalty Corp25.67-14662.98%
VRTXVertex Pharmaceuticals Inc27.99-15981.76%
RPRXRoyalty Pharma plc - Class A28.69-16374.80%
SLNOSoleno Therapeutics Inc29.02-16560.77%
ASNDAscendis Pharma A/S30.09-17167.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-21607.96%
APLSApellis Pharmaceuticals Inc39.02-22237.23%
BMRNBiomarin Pharmaceutical Inc42.21-24047.31%
KRYSKrystal Biotech Inc45.34-25823.92%
ONCBeiGene Ltd69.54-39551.18%
PHARPharming Group N.V.75.03-42662.98%
TECHBio-Techne Corp101.96-57942.31%
VCELVericel Corp109.92-62459.80%
ALNYAlnylam Pharmaceuticals Inc117.96-67023.13%
GMABGenmab140.29-79688.77%
TLXTelix Pharmaceuticals Ltd162.15-92091.40%
CORTCorcept Therapeutics Inc212.86-120856.82%